Cargando…
Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
Tumors promote immune suppression and dendritic cells (DCs) play a key role in this. However, signaling networks that program DCs to induce immune suppression are unknown. In our recent study, we showed that tumors activate β-catenin/TCF4 in DCs programming them to a regulatory state, which promotes...
Autores principales: | Suryawanshi, Amol, Manicassamy, Santhakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635893/ https://www.ncbi.nlm.nih.gov/pubmed/26587326 http://dx.doi.org/10.1080/2162402X.2015.1052932 |
Ejemplares similares
-
Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer
por: Suryawanshi, Amol, et al.
Publicado: (2016) -
Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity
por: Suryawanshi, Amol, et al.
Publicado: (2020) -
FOXO3: A master switch for regulating tolerance and immunity in dendritic cells
por: Watkins, Stephanie K., et al.
Publicado: (2012) -
Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013) -
Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)